Plain-English translation of NCT05448066 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a newer, more detailed type of allergy testing—called molecular-based diagnosis—helps doctors pick better immunotherapy treatments for allergies. Right now, doctors use standard allergy tests to decide on immunotherapy, but this trial wants to see if the advanced testing gives better results and helps your doctor choose the treatment that matches your specific allergies more precisely.
Immunotherapy is one of the most effective treatments for allergies, but doctors aren't sure if using advanced molecular testing to plan the treatment makes it work even better. This trial will help answer that important question and make sure patients get treatments tailored to their individual allergies.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups: one group will receive immunotherapy based on standard allergy testing alone, while the other group will have both standard testing and advanced molecular-based testing to guide their immunotherapy choice. You will be followed in the allergy clinic over time, and your doctors will track how well the treatment works for your allergies and symptoms.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Portugal